TCL Archive A Message From NCI: “We Deeply Regret The Need To Eliminate This Program.” AP4 Applicants And Corporate Partners Spent Years, Money, Before NCI Pulled The Plug On Novel Public-Private Partnerships. Von Eschenbach Called AP4 “A New Paradigm” For Drug Development. NCI Executive Committee “Prioritized” Programs. April 21, 2006
TCL Archive House Committee Probes NCI $5.2 Billion Sole-Source Contract With SAIC-Frederick. November 14, 2008
TCL Archive Kyprolis Demonstrates Overall Response Following FDA Accelerated Approval August 31, 2012
